LY4213663

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4213663, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis [Phase 1]